Griseofulviin (microsize)

Product NDC: 42254-306
11-digit product format: 422540306
Labeler code: 42254
Product ID: 42254-306_f1153794-33ae-4e9d-8c80-d29e01f82d77
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Griseofulvin (microsize)
Dosage form: SUSPENSION
Route: ORAL
Labeler: Rebel Distributors Corp
Application: ANDA065394
Marketing category: ANDA
Marketing start: 2007-07-26
Marketing end: 0000-00-00
Substance: GRISEOFULVIN
Active strength: 125 mg/5mL
Pharmacologic classes: Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	42254-306		I	Inactivated by FDA		2026-08-11
excluded package	package	42254-306	42254-306-04	I	Inactivated by FDA		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	42254-306-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	42254-306-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	42254-306-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	42254-306-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	42254-306-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	42254-306-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	42254-306-04	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	42254-306-04	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	42254-306-04	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	42254-306-04	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	42254-306-04	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	42254-306-04	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	42254-306-04	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	42254-306-04	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	42254-306-04	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	42254-306-04	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	42254-306-04	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	42254-306-04	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	42254-306-04	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	42254-306-04	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	42254-306-04	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	42254-306-04	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065394-001	GRISEOFULVIN	GRISEOFULVIN, MICROSIZE	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A065394-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065394-001	GRISEOFULVIN	125MG/5ML	SUSPENSION / ORAL	AB	RS	2007-07-06	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065394-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065394-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065394-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065394-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065394-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065394-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065394-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065394-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065394-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065394-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065394-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065394-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065394-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065394-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065394-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065394-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065394-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065394-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065394-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065394-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065394-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065394-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065394-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065394-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065394-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065394-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065394-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065394-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065394-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065394-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065394-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065394-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065394-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065394-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065394-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065394-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065394-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065394-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065394-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065394-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
50874f84-35e6-097e-94d8-7241c05d199f	Product name	2	20190416
024bc7a6-8e89-3d87-480f-f3ffc8f2ad80	Product name	1	20140508
0b9696ae-027f-1570-8c58-4178203eb52b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
42254-306-04	2019-09-24	C162847	48780-1	9350213a-3d22-c013-e053-90daa90a1393	GRISEOFULVIN ORAL SUSPENSION (microsize) USP, 125 mg/5 mL Rx Only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
42254-306-04	Griseofulviin (microsize)	120 mL in 1 BOTTLE	SUSPENSION	120		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42254-306-04	ML - Milliliter	42254-306	93b80ded-fc2a-4648-8e4c-511b73286051	1	2013-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GRISEOFULVIN	ACTIVE INGREDIENT	32HRV3E3D5	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
GRISEOFULVIN	ACTIVE MOIETY	32HRV3E3D5	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
DOCUSATE SODIUM	INACTIVE INGREDIENT	F05Q2T2JA0	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM ALUMINUM SILICATE	INACTIVE INGREDIENT	6M3P64V0NC	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
SODIUM ALGINATE	INACTIVE INGREDIENT	C269C4G2ZQ	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42254-306	GRISEOFULVIIN (MICROSIZE) (GRISEOFULVIN (MICROSIZE)) SUSPENSION [REBEL DISTRIBUTORS CORP]	1	Legacy NDC, 1 package rows	20130221_f1153794-33ae-4e9d-8c80-d29e01f82d77.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Griseofulvin	GRISEOFULVIN	Actavis Pharma, Inc.	af318d5d-cc39-4a63-a590-b87c50f2694f	2023-09-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065394 application number: ANDA065394

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
32HRV3E3D5	GRISEOFULVIN	126-07-8	GRISEOFULVIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
239238	griseofulvin 125 MG in 5 mL Oral Suspension	PSN	f1153794-33ae-4e9d-8c80-d29e01f82d77	1
239238	griseofulvin 25 MG/ML Oral Suspension	SCD	f1153794-33ae-4e9d-8c80-d29e01f82d77	1
239238	griseofulvin 125 MG per 5 ML Oral Suspension	SY	f1153794-33ae-4e9d-8c80-d29e01f82d77	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
42254-306-04	42254030604	120 mL in 1 BOTTLE	120 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GRISEOFULVIN ORAL SUSPENSION (microsize) USP, 125 mg/5 mL Rx Only	Rebel Distributors Corp \| PSS World Medical, Inc. \| STAT RX USA LLC \| Dispensing Solutions, Inc. \| SCRIPT PAK \| Keltman Pharmaceuticals, Inc. \| Rebel Distirbutors Corp.	2012-09-26	HUMAN PRESCRIPTION DRUG LABEL	1